tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF

Compare Newron Pharmaceuticals SpA (NWPHF) vs. Competitors

Compare
11 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
$9.36
$669.44M
6.81
0.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.37
CHF134.45M
-2.05
-33.40%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF54.10
CHF689.45M
9.47
39.24%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.74
CHF952.55M
-5.71
414.84%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF13.26
$184.55M
-2.59
0.15%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF25.30
CHF145.34M
4.68
0.80%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NWPHF
Newron Pharmaceuticals SpA
9.36
0.00
0.00%
CH:MOLN
Molecular Partners AG
3.33
-1.77
-34.71%
CH:BSLN
Basilea Pharmaceutica
56.60
16.05
39.58%
CH:IDIA
Idorsia Ltd
3.82
3.05
401.31%
CH:SANN
Santhera Pharmaceuticals Holding
13.26
-0.74
-5.29%
CH:XLS
Xlife Sciences Ltd.
25.20
-0.50
-1.95%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts